Home > Income Statement > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Revenue

    Back to Income Statement
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Revenue History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹152 Cr₹115 Cr₹85 Cr₹71 Cr₹42 Cr

What is the latest Revenue of BAFNA PHARMACEUTICALS ?

The latest Revenue ratio of BAFNA PHARMACEUTICALS is ₹152 Cr based on Mar2025 Standalone results.
Year Revenue
Mar2025₹152 Cr
Mar2024₹115 Cr
Mar2023₹85 Cr
Mar2022₹71 Cr
Mar2021₹42 Cr

How is Revenue of BAFNA PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹152 Cr
32.18
Mar2024 ₹115 Cr
35.48
Mar2023 ₹85 Cr
19.55
Mar2022 ₹71 Cr
67.68
Mar2021 ₹42 Cr -

Compare Revenue of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹491.9 Cr -4% 23.4% 173.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹464,331.0 Cr 1.2% 8.3% 15.5% Stock Analytics
DIVIS LABORATORIES ₹184,053.0 Cr -0.2% 3% -0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹165,952.0 Cr 1.7% 9.9% 46.8% Stock Analytics
CIPLA ₹115,263.0 Cr -2.2% 4.5% -4.4% Stock Analytics
DR REDDYS LABORATORIES ₹103,049.0 Cr -9% -2.1% -1.8% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-4%

23.4%

173.2%

SENSEX

-0.3%

4.9%

-7%


You may also like the below Video Courses